Rotavapor r-300 system and essential care
Ended Awarded Last action
- Contract number
- 75N95C22F00013
- Awardee
-
Pacific Star Corporation UEI QULRXKMBD576
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,677
Award facts
- Contract value 100% obligated
- $18,676.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334519 Other Measuring and Controlling Device Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Switzerland
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $5,112 | |
| Original award | $13,565 |
About this award
This federal contract award, valued at $18,676.73, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Pacific Star Corporation, a minority-owned, self-certified small disadvantaged business based in Houston, Texas. The contract is for the delivery of a ROTAVAPOR R-300 system and essential care items. It is a firm-fixed-price delivery order placed under Pacific Star Corporation's Multiple Award Schedule (MAS) contract with the General Services Administration (GSA). The contract has no set-aside designation and is associated with the Coronavirus COVID-19 National Interest Action. Pacific Star Corporation has established itself as a reliable supplier of medical equipment, laboratory supplies, and other mission-critical goods to various defense agencies, including the Defense Logistics Agency (DLA), through its extensive federal contract portfolio.
Quick answers
Who was awarded contract 75N95C22F00013?
75N95C22F00013 was awarded to Pacific Star Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on July 20, 2022.
How much is contract 75N95C22F00013 worth?
The government has obligated $18,677 on 75N95C22F00013.
Is contract 75N95C22F00013 an order under another contract?
Yes. 75N95C22F00013 is a delivery order under GS07F0111W, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N95C22F00013 competed?
The extent of competition for 75N95C22F00013 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award